GovChime
UEI: SN6SWFABJXL1 • CAGE: 1T9L5
Active

A&G PHARMACEUTICAL, INC. (MD)

DBA: Precision Antibody

Registration and award facts

SAM.gov registration as of

Net obligations recorded since FY2008 under this UEI: $4,176,649 across 55 awards and orders with positive net obligations.

Net obligations since FY2008
$4.18M
$4,176,649under this UEI
FY2026 obligations
-$27.7K
-$27,704Provisional
Awards and orders
55
with positive net obligations3 IDV vehicles held
Latest action
Aug 26, 2026
SAM.gov registration
Active
Registration expiration date Sep 21, 2027

Registration

UEI
SN6SWFABJXL1
CAGE code
1T9L5
Doing business as
Precision Antibody
Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Jun 6, 2000 (26 years)
Location
Columbia, MD
State of incorporation
Delaware
Purpose of registration
All Awards

SBA certifications

No certification in the SBA profile data.

NAICS codes

Product and service codes (PSC)

  • B504SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL
  • AN13R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT)
  • 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
  • 6505DRUGS AND BIOLOGICALS
  • AN22R&D- MEDICAL: DRUG DEPENDENCY (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)

Federal contract obligations

Net obligations recorded under this UEI since FY2008. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2026: -$27,704 (de-obligation) (provisional)
  • FY2025: $24,896
  • FY2024: $93,920
  • FY2023: $43,584
  • FY2022: $66,447
  • FY2021: $132,689
  • FY2020: $43,944
  • FY2019: $169,992
Show all 19 years
  • FY2018: -$3,456 (de-obligation)
  • FY2017: -$17,178 (de-obligation)
  • FY2016: $29,546
  • FY2015: $1,113,032
  • FY2014: $1,662,055
  • FY2013: $320,998
  • FY2012: $255,530
  • FY2011: $150,420
  • FY2010: $73,785
  • FY2009: $13,300
  • FY2008: $30,850

Total across 19 fiscal years: $4,176,649

Net de-obligation in that fiscal year (obligations withdrawn).

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • AN11R&d- medical: biomedical (basic research)$3,293,389, 78.9%
  • 6505Drugs and biologicals$477,940, 11.4%
  • 6509Drugs and biologicals, veterinary use$122,676, 2.9%
  • Q301Medical- laboratory testing$97,282, 2.3%
  • 6640Laboratory equipment and supplies$59,460, 1.4%

† FY2026 obligations (provisional; DoD awards signed after Jul 23, 2026 are not yet public).

Latest awards and orders

  1. 75N93021P01162Purchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  2. 75N98024A00057Blanket purchase agreement (BPA)VehicleDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  3. 75N95022F00001Delivery orderunder an indefinite delivery contract (IDC)Department of Health and Human ServicesNational Institutes of HealthLatest action
  4. 75N93024P01059Purchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  5. 75N95C25P00114Purchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  6. 75N93025P00729Purchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  7. 75N91020P00499Purchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  8. 75N91019P00615Purchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  9. 75N95019F00088Delivery orderunder an indefinite delivery contract (IDC)Department of Health and Human ServicesNational Institutes of HealthLatest action
  10. 75N93019P01122Purchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI SN6SWFABJXL1. GovChime does not check exclusions.

Key Performance Statistics

View obligations by year, agencies and performance history

Capabilities

NAICS Codes

See all industry codes with contract counts

Product/Service Codes

As of . Source: SAM.gov Goods & Services.

B504- SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL
AN13- R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT)
6550- IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
6505- DRUGS AND BIOLOGICALS
AN22- R&D- MEDICAL: DRUG DEPENDENCY (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)

Certifications

Business Types

Business or OrganizationFor Profit Organization

Federal Capability Statement

Precision Antibody™ service rapidly develops customized, high-affinity monoclonal & polyclonal antibodies to your target antigen. We also offer both in vivo and in vitro monoclonal antibody production, from pilot scale to large-scale manufacturing.

Capabilities & Services

Monoclonal antibody
MAB service
custom antibodies
therapeutic
diagnostic

Contracts

Explore federal contract awards with detailed transaction history

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for A&G PHARMACEUTICAL, INC. lists a physical address and a separate mailing address, along with 4 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

9130 RED BRANCH RD STE U

COLUMBIA, MD, 21045

USA

Mailing Address

DBA: PRECISION ANTIBODY

9130 RED BRANCH ROAD - STE U

COLUMBIA, MD, 21045

USA

Government Business Contact

Stephanie Murcek

Office Manager

9130 RED BRANCH ROAD

Columbia, MD, 21045

USA

Electronic Business Contact

Ginette Serrero

9130 RED BRANCH ROAD

Suite X

Columbia, MD, 21045

USA

Government Business Alternate Contact

GINETTE SERRERO

CEO

9130 RED BRANCH ROAD

SUITE X

Columbia, MD, 21045

USA

Electronic Business Alternate Contact

Stephanie Murcek

Office Manager

9130 RED BRANCH ROAD

Columbia, MD, 21045

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

A&G PHARMACEUTICAL, INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires September 21, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Entity Structure:Corporate Entity (Not Tax Exempt)
Profit Structure:For Profit Organization
CAGE Code:1T9L5

Registration Details

Source: SAM.gov

Date Founded

Jun 6, 2000

Initial Registration

Jun 8, 2001

Last Update

Sep 22, 2026

Registration Activation

Active — Sep 22, 2026

Registration Expiration

Sep 21, 2027

Fiscal Year End

12/31

State of Incorporation

DE

Country of Incorporation

USA

Congressional District

03

Entity Website